Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bruker Daltronics
CRO
Bruker expands CRO plans with Biognosys majority ownership deal
Bruker is expanding its CRO business through a majority ownership deal with Biognosys, which produces proteomics solutions for clinical trials.
Joseph Keenan
Jan 4, 2023 3:15pm
FDA to encourage use of mass spec to identify microorganisms
Apr 23, 2018 7:58am
AMRI partners with Bruker, HighRes in mass spectrometry for drug discovery
Feb 8, 2017 1:50pm
